Wall Street brokerages expect Greenbrook TMS Inc. (NASDAQ:GBNH Get Rating) to report sales of $15.10 million for the current quarter, according to Zacks. Three analysts have issued estimates for Greenbrook TMSs earnings, with the highest sales estimate coming in at $15.70 million and the lowest estimate coming in at $14.60 million. Greenbrook TMS reported sales of $13.71 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 10.1%. The business is scheduled to report its next quarterly earnings results on Monday, January 1st.<\/p>\n
On average, analysts expect that Greenbrook TMS will report full year sales of $63.47 million for the current financial year, with estimates ranging from $57.30 million to $68.00 million. For the next fiscal year, analysts forecast that the company will post sales of $78.93 million, with estimates ranging from $63.40 million to $101.00 million. Zacks Investment Researchs sales averages are an average based on a survey of sell-side research analysts that cover Greenbrook TMS.<\/p>\n
Greenbrook TMS (NASDAQ:GBNH Get Rating) last issued its quarterly earnings results on Friday, May 13th. The company reported ($0.44) earnings per share (EPS) for the quarter. Greenbrook TMS had a negative net margin of 46.27% and a negative return on equity of 157.80%. The company had revenue of $13.07 million during the quarter, compared to analyst estimates of $11.70 million. During the same quarter last year, the firm earned ($0.56) EPS. <\/p>\n
NASDAQ:GBNH opened at $2.34 on Friday. Greenbrook TMS has a 12-month low of $2.01 and a 12-month high of $13.89. The company has a current ratio of 0.95, a quick ratio of 0.95 and a debt-to-equity ratio of 4.31. The stocks 50 day simple moving average is $2.61 and its 200-day simple moving average is $3.68. The firm has a market cap of $41.66 million, a P\/E ratio of -1.58 and a beta of 2.25. <\/p>\n
Institutional investors and hedge funds have recently modified their holdings of the business. Rockefeller Capital Management L.P. acquired a new stake in shares of Greenbrook TMS during the 3rd quarter valued at approximately $109,000. Royal Bank of Canada grew its holdings in shares of Greenbrook TMS by 243.1% in the 3rd quarter. Royal Bank of Canada now owns 6,848 shares of the companys stock worth $51,000 after acquiring an additional 4,852 shares during the period. Masters Capital Management LLC increased its stake in Greenbrook TMS by 80.0% in the 3rd quarter. Masters Capital Management LLC now owns 450,000 shares of the companys stock valued at $3,339,000 after purchasing an additional 200,000 shares in the last quarter. AdvisorShares Investments LLC raised its holdings in Greenbrook TMS by 365.5% during the fourth quarter. AdvisorShares Investments LLC now owns 64,214 shares of the companys stock worth $281,000 after purchasing an additional 50,418 shares during the last quarter. Finally, Royce & Associates LP boosted its position in Greenbrook TMS by 8.0% during the fourth quarter. Royce & Associates LP now owns 223,500 shares of the companys stock worth $977,000 after purchasing an additional 16,598 shares in the last quarter. Institutional investors own 16.73% of the companys stock. <\/p>\n
About Greenbrook TMS (Get Rating)<\/p>\n
Greenbrook TMS Inc, together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services.<\/p>\n
Featured Stories<\/p>\n
Get a free copy of the Zacks research report on Greenbrook TMS (GBNH)<\/p>\n
For more information about research offerings from Zacks Investment Research, visit Zacks.com<\/p>\n
Receive News & Ratings for Greenbrook TMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Greenbrook TMS and related companies with MarketBeat.com's FREE daily email newsletter.<\/p>\n
<\/p>\n
Read more here: <\/p>\n
$15.10 Million in Sales Expected for Greenbrook TMS Inc. (NASDAQ:GBNH) This Quarter - Defense World<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Wall Street brokerages expect Greenbrook TMS Inc. (NASDAQ:GBNH Get Rating) to report sales of $15.10 million for the current quarter, according to Zacks. Three analysts have issued estimates for Greenbrook TMSs earnings, with the highest sales estimate coming in at $15.70 million and the lowest estimate coming in at $14.60 million. Continue reading